✦ LIBER ✦

P-138 New approaches for risk assessment of patients with myelodysplastic syndrome

✍ Scribed by Micheva, I.; Gerov, V.; Rachev, R.; Varbanov, H.; Efraim, M.; Stavrev, N.; Angelova, L.; Gercheva, L.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cause of death in patients with lower-ri

✍ Farshid Dayyani; Anthony P. Conley; Sara S. Strom; William Stevenson; Jorge E. C 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 212 KB

P-319 Experience with the use of azaciti

✍ Duarte, F.; Santos, T.; Barbosa, M.; Santos, T.; Goncalves, R. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 97 KB

Utility of the p53 mutant protein in pat

✍ Yao, David C.; de Lima, Marcos 📂 Article 📅 2014 🏛 SciELO 🌐 English ⚖ 324 KB

Long-term outcome of immunosuppressive t

✍ Hata, Tomoko; Tsushima, Hideki; Baba, Maki; Imaizumi, Yoshitaka; Taguchi, Jun; I 📂 Article 📅 2013 🏛 Carden Jennings Publishing 🌐 English ⚖ 304 KB

Anemia for Risk Assessment of Patients W

✍ Nicolas Meneveau; François Schiele; Marie-France Seronde; Vincent Descotes-Genon 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 250 KB

P-304 5-azacytidine in the treatment of

✍ Zervakis, K.; Diamantopoulos, P.; Papadopoulou, V.; Iliakis, T.; Mpakarakos, P.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 67 KB